FDA Approved: MICAFUNGIN — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma Pharmaceuticals USA Inc.'s original ANDA for micafungin sodium injectable (micafungin).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infections Prophylaxis in Hematopoietic Stem Cell Transplant Recipients
• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis

Drugs mentioned

• Micafungin (micafungin)

Snippet

ORIG AP for MICAFUNGIN (MICAFUNGIN SODIUM)